|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3464380 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17734131.0 |
| Date of filing the European patent application | 2017-06-02 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-11-06 |
| (46) | Date of publication of the claims translation | 2025-02-10 |
| (86) | Number | PCT/GB2017/051596 |
| Date | 2017-06-02 |
| (87) | Number | WO 2017/208018 |
| Date | 2017-12-07 |
| (30) | Number | Date | Country code |
| 201609683 | 2016-06-02 | GB | |
| 201612193 | 2016-07-13 | GB | |
| 201612260 | 2016-07-14 | GB |
| (72) |
COUGHLIN, Christina , US
|
| (73) |
Immunocore Limited ,
92 Park Drive
Milton Park, Abingdon, Oxfordshire OX14 4RY,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | GP100 specifinio TCR - anti-CD3 SCFV sulieto baltymo dozavimo schema |
| DOSING REGIMEN FOR GP100-SPECIFIC TCR - ANTI-CD3 SCFV FUSION PROTEIN |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 9 | 208.00 EUR |
| 2026-06-02 |